Abstract | The ancient biological 'arms race' between microbial pathogens and humans has shaped genetic variation in modern populations, and this has important implications for the growing field of medical genomics. As humans migrated throughout the world, populations encountered distinct pathogens, and natural selection increased the prevalence of alleles that are advantageous in the new ecosystems in both host and pathogens. This ancient history now influences human infectious disease susceptibility and microbiome homeostasis, and contributes to common diseases that show geographical disparities, such as autoimmune and metabolic disorders. Using new high-throughput technologies, analytical methods and expanding public data resources, the investigation of natural selection is leading to new insights into the function and dysfunction of human biology.
Infectious pathogens are arguably among the strongest selective forces that act on human populations 1 . Migrations and cultural changes during recent human evolutionary history (the past 100,000 years or so) exposed populations to dangerous pathogens as they colonized new environments, increased in population density and had closer contact with animal disease vectors, including both conventionally domesticated animals (for example, dogs, cattle, sheep, pigs and fowl) and those exploiting permanent human settlement (for example, rodents and sparrows) 2,3 . Consequently, both birth and mortality rates increased markedly 4 . Host genetics strongly influences an individual's susceptibility to infectious disease 5, 6 . Pathogens that diminish reproductive potential, either through death or poor health, drive selection on genetic variants that affect resistance; selection is likely to be most evident for pathogens with a long-standing relationship with Homo sapiens, including those that cause malaria, smallpox, cholera, tuberculosis and leprosy 7 (FIG. 1) . We also contend with new threats, such as AIDS and severe acute respiratory syndrome (SARS). Some pathogens cause acute illnesses such as smallpox and cholera but, once survived, pose little additional threat. Other pathogens -for example, those causing malaria, tuberculosis and leprosy, as well as parasitic worms -can be carried as chronic infections and impair nutrition, growth, cognitive development and fertility. The timing, strength and direction (that is, positive, negative or balancing) of selection shape the patterns of variation that remain in the genome. These signatures of selection will therefore vary with the age, geographical spread and virulence of the pathogen.
For those with access, modern medicine radically diminishes exposure to various pathogens. In developed countries, vaccination, better nutrition and improved public health have eliminated diseases that were common in the past 8 . Common immune-mediated diseases may be partly caused by evolutionary adaptations for resistance and symbiosis with potentially dangerous microorganisms [9] [10] [11] [12] . For example, decreased gut microbiome diversity in residents of developed countries 13 may alter mucosal immune responses 14 . Understanding hostpathogen interactions will inform the development of new therapies both to counter ongoing pathogen evolution and to better manage immune-mediated diseases 15 . Here, we review how the technological revolution in genomics allows us to examine human adaptation to infectious disease in new ways. Natural selection leaves distinctive signatures in the genome, as genetic variants that improve survival and reproduction increase in frequency, and detrimental variants vanish. Hundreds of candidate regions of selection were identified in early genomic data sets, but only few adaptive variants were identified 16 . High-throughput biotechnology enables large-scale surveys of genome diversity, genome-wide association studies (GWASs), next-generation sequencing, and high-throughput experimental and bioengineering approaches 17 . Together with expanding computational capacity 18 , these tools offer new power to find and functionally elucidate adaptive changes. Pathogen susceptibility and immune traits are particularly amenable
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to mapping approaches that combine scans for natural selection and genetic association. We consider how these new genomic analyses provide insights into human evolution and have implications for human health. We focus primarily on examples in which selection is connected to infectious disease susceptibility through additional phenotypic associations or functional investigations.
Methods and technologies
Signatures of selection. Natural selection is the tendency for traits to increase or decrease in frequency in a population depending on the reproductive success of those exhibiting them. Positive selection increases the frequency of favoured alleles, negative selection eliminates detrimental alleles, and balancing selection favours diversity. This process leaves unusual patterns of genetic diversity that mark selected loci (that is, signatures of selection) when compared with the background distribution of genetic variation in the genome, which is assumed to evolve under neutrality to a large extent 19 . Population events that alter genetic diversity -including bottlenecks, expansions, splits and admixturecomplicate accurate detection of selected loci.
Scans for natural selection have been made possible by statistical tools to detect signatures of selection and by rapidly expanding whole-genome data sets in multiple human populations. Whereas early scans relied on single-nucleotide polymorphism (SNP) genotyping arrays, next-generation sequencing technologies now enable generation of whole-genome sequence data sets for analysis. Such data sets have several advantages. They do not suffer from ascertainment bias, which is the distortion in measures of genetic diversity and neutral variation 20 created by the nonrandom sampling of SNPs on arrays. In addition, sequence data make it feasible to dissect loci with complex patterns of selection and short blocks of linkage disequilibrium (LD), such as the haemoglobin beta (HBB) gene that is associated with sickle cell anaemia 21 . Finally, as sequencing can detect potentially all variation throughout an individual's genome, the search for the precise causal variant driving selection is facilitated; however, as for SNP genotyping arrays, the comprehensiveness of capturing population-wide variation will depend on the number of individuals sampled.
Here, we briefly describe a few commonly used signatures that can help to elucidate human adaptations to pathogens. Various excellent resources provide more detailed background on statistical methods for detecting selection [22] [23] [24] [25] [26] .
Signatures of positive selection. Positive selection increases the prevalence of genetic variants that improve survival and fertility. For example, a mutation that protects against malaria by disrupting expression of the Duffy antigen gene DARC (also known as FY), which encodes the receptor used by the Plasmodium vivax malarial parasite to enter red blood cells, has reached fixation in most of sub-Saharan Africa 27 . Positive selection can act on new variants or on standing variation that becomes favourable owing to environmental changes 28, 29 . The test used to detect positive selection depends on when the selection occurred and on whether the variant is standing or new 28 . Very ancient selection may leave an excess of fixed, functional (for example, protein-coding) genetic changes that have been acquired over millions of years and through repeated selective sweeps. A selected variant that increases rapidly in frequency in the past ~250,000 years can be detected as an unusual reduction in genetic diversity. Recent positive selection (within the past 5,000-100,000 years) can be found with three different signals: unusually large allele frequency differences between populations, unusually high frequency of newly derived variants and unusually extended LD caused by the rapid increase in frequency of a single allele. The LD-based methods 30 are particularly useful for detecting incomplete sweeps (that is, variants increasing in prevalence but not to fixation), which are more common in recent human evolution than complete sweeps [31] [32] [33] [34] . Key events in recent human evolution (boxes outlined in black) are juxtaposed with the estimated ages of infectious disease emergence (boxes outlined in red). The fragmentation of the human lineage into genetically and geographically distinct populations (blue lines) accelerates with migration out of Africa. Later, these populations started mixing more (blue shaded regions between the populations) along trade routes (such as the Silk Road), through colonization and through high rates of global travel nowadays. 
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Candidate gene approach
Association study that tests only variants in a pre-specified set of genes.
These methods have detected hundreds of loci with signatures of selection in the human genome 16, 28, 30, [35] [36] [37] [38] [39] [40] [41] . Their sensitivity to recent events depends on the strength of selection, as more advantageous variants increase to detectable frequencies faster. The comparison of many individuals from closely related populations using treebased methods can help to detect smaller selectiondriven changes in allele frequencies 42 . Combining several different tests for selection improves sensitivity to a wider range of selection regimes, helps to narrow down candidate regions and pinpoints a small number of top causal candidates 28, 33, 43 . Pathogen resistance alleles are prime candidates for discovery, as they are likely to be both recent and common, and have increased in frequency owing to the burden of disease.
Signatures of balancing selection. Balancing selection maintains multiple alleles at a locus. A variant may confer a heterozygous advantage; for example, at the HBB sickle cell locus, heterozygous carriers are malaria resistant to a large extent but otherwise healthy, which gives them a reproductive advantage in malaria-endemic environments over homozygous wild-type individuals (who are susceptible to malaria) and homozygous carriers (who have sickle cell disease and high childhood mortality 27 ). Alternatively, the advantage conferred by a variant may depend on its prevalence. Diversifying selection favours high levels of polymorphism, as in the major histocompatibility complex (MHC). MHC diversity confers resistance to a broader range of pathogens 44 and is strongly selected for 45 . In humans, MHC diversity correlates with local pathogen diversity, which is consistent with pathogen-driven balancing selection 46 . Selection at this locus is of particular interest, as it harbours more bona fide disease associations than any other region in the human genome 47, 48 , including associations to infectious disease susceptibility (including AIDS [49] [50] [51] , leprosy 52 , leishmaniasis 53 , hepatitis B [54] [55] [56] , hepatitis C 57 and human papilloma virus (HPV) infection 58 ), autoimmune disorders, cancers and neuropsychiatric diseases.
Recent balancing selection can resemble an incomplete selective sweep and be detected using LD-based tests for positive selection, as at the HBB sickle cell locus 59, 60 . Long-term balancing selection reduces the number of rare alleles in a region and causes an excess of polymorphism, an excess of intermediate-frequency variants and reduced allele frequency differences between populations 61 . Cross-species comparative sequence analysis is particularly effective for detecting the subtle signals of ancient balancing selection. A comparison of humans and non-human primates found that both the MHC 61 and the blood group locus ABO 62, 63 contain ancient multiallelic polymorphisms maintained across species, which indicates balancing selection. A comparison of wholegenome sequences for 10 chimpanzees and 59 humans found that regions with signatures of balancing selection -MHC and 125 other loci 64 -were enriched for membrane glycoproteins. These are proteins exploited by a broad range of pathogens as receptors for cell invasion and to evade the host immune response, which suggests that the selection was pathogen driven [65] [66] [67] .
Signatures of negative selection and purifying selection.
Negative selection eliminates existing detrimental variation from a population 68 . For example, when human populations in the Ganges River Delta encountered pathogenic Vibrio cholerae, individuals of blood type O had higher risk of dying from severe cholera, which put them at a strong reproductive disadvantage. Nowadays, populations in the cholera-endemic Ganges River Delta have the lowest rates of blood type O in the world, which is consistent with negative selection 69, 70 . Purifying selection is the ongoing removal of deleterious alleles as they arise. Signatures of purifying selection include decreased overall diversity, loss of functional variation and an excess of rare alleles 68 . Purifying selection also manifests as a lack of substitutions between species, and this signal is used to identify functionally important, highly conserved genomic regions in cross-species comparisons 71 .
GWASs of adaptive traits. GWASs identify genomic variants that are significantly correlated with a phenotype of interest, typically in large sample cohorts. The sample size required is smaller if variants are at high prevalence, have strong effects and are in regions of extensive LD 72, 73 , all of which are characteristics of positively selected loci (FIG. 2) . As beneficial alleles increase in prevalence, they carry nearby variants with them (known as genetic hitchhiking); these nearby variants can thus be proxies for the causal allele and enhance power to detect association.
The US National Institutes of Health (NIH) Catalog of published GWASs includes all strong SNP-trait associations (P < 1 × 10 −5
) from 1,900 curated publications 48 . However, only 68 publications are related to pathogen susceptibility, and most of those (63%) are focused on AIDS (16 studies), hepatitis B (12 studies) and hepatitis C (15 studies). The remainder includes GWASs of tuberculosis (5 studies), prion diseases (3 studies), malaria (3 studies), leprosy (2 studies), smallpox (2 studies) and 9 others (see Supplementary information S1 (table) ). Before GWASs, a candidate gene approach was used to find strong-effect variants that were associated with disease susceptibility in HBB, DARC and SLC4A1 (solute carrier family 4 (anion exchanger), member 1 (Diego blood group)) for malaria, and the CCR5 (chemokine (C-C motif) receptor 5) gene for AIDS 74 . However, candidate gene studies were generally underpowered, and beyond these textbook examples most previous associations have so far failed to replicate in GWASs 75 . For example, of 22 tuberculosis-associated genes, none were significantly associated in a GWAS of 11,425 Africans, nor were these genes overrepresented among nominally significant results [76] [77] [78] . Candidate gene studies of infectious disease susceptibility have been reviewed in detail elsewhere 79 .
Integrating selection metrics into GWASs can increase their power. A study of malaria resistance loci in Africa found that when association results are weighted on the basis of evidence of positive selection, 
Pathway-based approaches
Methods that test for joint association of genes in the same functional pathway.
Expression quantitative trait loci
(eQTLs). Genomic loci that regulate gene expression.
power increases by 1-2 orders of magnitude 80, 81 . Another approach was used to identify positively selected drug resistance loci in the malaria parasite Plasmodium falciparum; the sample was partitioned into two populations defined by phenotype (for example, resistant and susceptible), and regions of selection were identified in resistant individuals 82 . Furthermore, as described above, selection increases the power of GWASs themselves by driving the emergence of common alleles of strong effect. Indeed, using the Kolmogorov-Smirnov test, we found that variants in positively selected regions in the NIH Catalog of published GWASs are more significantly associated with the tested phenotype (P KS = 2 × 10 −7 ) than those in the rest of the genome 33 .
Signatures of polygenic selection. Similar to many other human traits, adaptation to pathogens is likely to be polygenic 33, 83 , as mutations in many genes emerge and increase in prevalence through selection. Pathwaybased approaches scrutinize candidate regions identified in GWASs 84 to elucidate functional pathways that are disrupted in complex human diseases 85 . The same approach can be applied to candidate selected regions; however, as natural selection acts on many traits, they are less powered. Only when a particular pathway is repeatedly selected for in a population, such as skin pigmentation in Europeans, do we expect significant enrichment.
Functional characterization.
For an allele to be selected it must have a functional effect, but the relevant phenotype is typically unknown. Selected regions therefore present an opportunity to develop a systematic process for functionally characterizing genetic variation. In a few cases, a selected region contains well-characterized genes that offered clear functional hypotheses, for example, Toll-like receptor 5 (TLR5, which is involved in bacterial flagellin sensing 33 ) (FIG. 3A) , apolipoprotein L1 (APOL1, which encodes a serum factor that lyses Trypanosoma brucei 86 ) (FIG. 3B) and HBB (which influences infection by P. falciparum 27 (see above)). For genes with unknown or diverse functions, identification of the selected trait is more complicated. Moreover, most selection signals are non-genic and are likely to alter poorly characterized regulatory regions of the genome 43, 87, 88 .
Functional elucidation remains a difficult and mostly manual process, and benefits enormously when candidate variants are narrowed down to a small number. New methods for detecting selection are remarkably effective at identifying top functional candidates among all variants in selected regions -a list that can be further reduced by incorporating GWAS results, expression quantitative trait loci (eQTLs) and functional annotations 33, 89 . Useful resources include the 1000 Genomes Project, which aims to identify all common (>1%) human genetic variation by sequencing >1,000 individuals 90 , and the Encyclopedia of DNA Elements (ENCODE) Project, which aims to characterize all functional elements in the genome 91 . Breakthroughs in next-generation sequencing, high-throughput functional screens, single-cell genomics, microfluidics, chromosome conformation capture and genome engineering approaches now make it possible to test many variants in parallel, to investigate non-genic regions and to functionally screen the whole genome 17, [92] [93] [94] [95] [96] [97] [98] [99] .
Genetics of infectious disease resistance
The dynamics of host-pathogen interactions (for example, length of exposure, geographical spread, morbidity and mortality, and co-occurring environmental events) influences the genetic architecture of resistance variants in modern populations (FIG. 4) . Many different modes of selection shape patterns of variation in humans (reviewed in REFS 25, 26) , and selection scans using current methods and data sets can only detect a subset of selected loci. The most conspicuous signals are perhaps left by positive selection in recent human evolutionary history. This is the timeframe during which many major pathogens first emerged (FIG. 1; TABLE 1 ), which suggests that this mode of selection is particularly relevant to studies of infectious disease susceptibility. Moreover, finding beneficial variants that are favoured by recent selection could suggest new medical therapies. Transforming genetic discoveries into improved healthcare will take time, but understanding natural resistance is an important first step.
We note that some have questioned the extent of recent positive selection in humans in light of a recent paper 31 . In that paper, the authors estimated that during the past 250,000 years, ~0.5% of nonsynonymous substitutions have swept to fixation (that is, 100% prevalence), and such an observation has been interpreted to suggest that very few positively selected variants can be found in humans. In actuality, this corresponds to The red region indicates a variant that provides selective advantage (such as a host variant that confers relative resistance to an infectious agent). Positive selection of that variant rapidly increases its prevalence in a population and also the prevalence of nearby alleles that are in linkage with it. b | Positive selection on a variant is detectable with three types of signals: high levels of differentiation (that is, when positive selection in one geographical region causes larger frequency differences between populations than those expected for neutrally evolving alleles); high frequency of the derived allele (that is, when a new allele increases to a frequency higher than that expected under genetic drift); and long haplotypes (as determined by the integrated haplotype score and cross-population extended haplotype homozygosity) that are left when the selected allele increases in frequency sufficiently quickly that long-range associations with neighbouring variants are maintained. Combining different signals of selection into a composite score can increase resolution by up to 100-fold, which facilitates identification of the causal variants. c | Variants that are of high frequency, of strong effects and in regions of extensive linkage disequilibrium (LD) -all of which are characteristics of positively selected loci -are detectable with smaller sample sizes in genome-wide association studies (GWASs). Even with full sequence data, low-frequency alleles (solid blue lines) require larger sample sizes (x axis; equal number of cases and controls) than high-frequency alleles (solid red lines) for equivalent power over a range of effect sizes (1.2, 1.5 and 2.0). When mapping with genotyping arrays, shorter LD in unselected regions (blue dashed lines; modelled here using power simulations for the sparser Illumina 300K array) can cause a larger loss of power (relative to full sequence data) than in selected regions with longer LD (red dashed lines; modelled as denser Illumina 1M array). 
~340 adaptive nonsynonymous mutations in the 1000
Genomes Project data. Moreover, much (probably most) adaptive evolution occurred in regulatory, noncoding regions 100, 101 , and most recent selective sweeps are far from complete 102 . Thus, the actual number of positively selected loci could be much larger.
Under the framework of recent positive selection, one would anticipate that genetic variants conferring pathogen resistance that are moderately old (dating since the human migrations from Africa but at least thousands of years old), that were geographically limited in history and that exerted strong positive selective pressure will be most readily detected, provided that the studies are carried out in the population with the history of disease exposure. Many of the pathogen studies so far are imperfect fits for these criteria. Here, we review some of the prominent diseases of human history (TABLE 1) , and discuss the strengths and limitations of investigating natural selection and association for these traits.
Malaria. Malaria is caused by obligate parasitic
Plasmodium spp., which infects hundreds of millions of people and kills ~1 million children annually 103 . P. falciparum has afflicted humans for ~100,000 years, and a rapid upsurge of malaria ~10,000 years ago increased selective pressure on some human populations 27, 104 . As a result, incidence of sickle cell disease and other inherited red blood cell disorders that are associated with malaria resistance (for example, α-thalassemia, glucose-6-phosphate dehydrogenase (G6PD) deficiency and ovalocytosis) coincides with the geographical distribution of malaria 27 . The presence of a disease in a population may indicate that the pathogen exerts selective pressure, but the inverse -absence of disease -can also be meaningful. Although P. falciparum is common in sub-Saharan Africa, P. vivax is noticeably absent. A mutation in the human DARC gene 105 that disrupts expression of the Duffy antigen receptor to prevent infection 106 has become 100% prevalent. In a possible example of For pathogens that predate human dispersal from Africa, ancient and complex signals of selection are shared between human populations, and there are variable implications for genome-wide association studies (GWASs). For widespread pathogens that are more recent, the range of new resistance variants will be more limited, but selection is harder to detect when it is shared between populations. For recent pathogens that affect specific populations, GWASs in the selected populations will be particularly powerful, as causal variants will have been driven to high prevalence. Selection signals from one population may help to detect resistance loci in other unselected populations, but only if resistance variants arise in the same genetic loci. For GWASs of very new diseases, supplementing these studies with methods to detect selection will add no power, unless variants that confer resistance also protect against more ancient pathogens. Examples of pathogens matching each scenario are given on the right. convergent evolution, an independent DARC mutation is prevalent in Southeast Asia where P. vivax is common 107 . As expected in the host-pathogen evolutionary 'arms race' , the high prevalence of Duffy-negative hosts could be driving P. vivax to adapt. Strains of P. vivax have emerged in Africa that can infect Duffy-negative individuals 108 and that carry new variants of the gene encoding Duffy-binding protein 109 .
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The long history and strong selective pressure exerted by malaria may paradoxically complicate detection of resistance loci by GWASs. When selection drives multiple resistance variants to arise in a locus (for example, HBB and MHC), patterns of selection and association are more complex. Further complicating GWASs of malaria susceptibility, most cases occur in African populations, in which LD is short and highly variable between populations. Thus, causal variants are poorly tagged by SNP genotyping arrays 21, 110 . Methods that successfully tackle these challenges are being developed, including GWASs by sequencing, improved imputation and Bayesian statistical approaches that allow heterogeneity in effect size and location [110] [111] [112] . An initial malaria GWAS in West Africa with 2,500 cases, 3,400 controls and 400,000 SNPs found no genome-wide significant associations 21 . Increasing the sample set to 3,500 cases, 4,300 controls and 800,000 SNPs (4 million after imputation) found HBB, ABO and two novel loci: one is intergenic and the other is in the ATP2B4 gene, which encodes an erythrocyte calcium channel 111 . An international collaborative GWAS of severe malaria is likely to identify more loci 113 .
Leprosy. Leprosy is a chronic disease caused by the bacterium Mycobacterium leprae and causes infertility, disfiguring skin lesions, social ostracism, permanent physical disability and shortened life span [114] [115] [116] [117] [118] . M. leprae is an ancient and obligate human pathogen with a phylogeography that follows human migrations 119 . Although not immediately fatal, leprosy infection decreases fertility 118 by up to 85% 120 , which poses a potent selective pressure. Consistent with selection that favours resistance variants, most people nowadays are genetically protected against M. leprae 121 . Indeed, host genetics has such a large role in susceptibility that, before the disease was proved to be caused by bacteria, leprosy was thought to be an inherited disease rather than an infectious one 122, 123 . Leprosy was endemic in Europe with a prevalence of 10-40% 124 until the sixteenth century; its subsequent rapid decline is still unexplained. Currently, it remains a major public health burden in India, China and South America 125 . The genetics of leprosy susceptibility differs between populations. GWASs in Han Chinese implicated the bacterial pattern recognition receptor NOD2 and three other components of NOD2-mediated innate immunity 52, 126 , but these associations did not replicate in an independent study of Indians and Malawians 127 . The Indian cohort instead had strong association to a functional knockout mutation in the TLR1 gene that protects against leprosy 128 . This variant is nearly absent in the Han Chinese population (2%) and rare in Indians (9%) but extremely common in Europeans (70%) 129 owing to positive selection 130 . A locus associated with leprosy susceptibility in Chinese populations that is near the immune regulator gene cylindromatosis (CYLD) 131, 132 may also be positively selected in Europeans (FIG. 5) . Selection at leprosy-associated loci in European populations, together with the evidence from Indian and Chinese studies that risk loci differ between populations, suggests that combining European selection scans with a European GWAS might offer the most power. However, as leprosy is now rare in Europe, a GWAS would require a phenotypic proxy. Alternatively, as technology improves for analysing ancient DNA samples, thousands of medieval skeletal remains in Europe, many of which have lesions indicative of leprosy 124 , may be usable in archaeological GWASs.
Tuberculosis.
Tuberculosis is an often lethal disease caused by Mycobacterium tuberculosis, which infects one-third of the human population. Similar to the pathogens causing malaria and leprosy, M. tuberculosis is an ancient and obligate human pathogen that is estimated to have emerged in East Africa ~40,000 years ago 133 and to have spread around the world with ancient human migrations 134 . Consistent with long host-pathogen coevolution, only 10% of infected individuals develop active disease; in most infected individuals the host immune system contains the pathogen. Host genetic factors are strongly implicated in susceptibility 135 . Despite this, a GWAS of tuberculosis susceptibility found only 2 significant associations in a huge data set 
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Overrepresentation of an a priori defined group of genes. of 11 million SNPs and, after replication, nearly 23,000 individuals 76, 136 , compared with 490,000 SNPs and 9,200 individuals in the leprosy GWAS 136 . What explains the different outcomes of the tuberculosis and leprosy GWASs? One possible factor is that M. tuberculosis is more genetically diverse than M. leprae 134 , and particular lineages of M. tuberculosis may have adapted to specific populations 137 . As individual tuberculosis status varies with how the host genetics interacts with the infecting M. tuberculosis strain, an accurate phenotype would include sequence data from the pathogen. In addition, tuberculosis resistance can be defined either as preventing or containing infection. Finally, co-infection with other pathogens increases the risk of developing active tuberculosis (for example, HIV infection increases risk by 21-34-fold 138 ). Phenotypic ambiguity, strain differences and strainhost interactions reduce the power of GWASs to associate host genetic factors with tuberculosis susceptibility 139 , but the evidence of host-pathogen co-evolution suggests that incorporating tests of selection into GWASs may be particularly powerful. The strongest association so far is found in a GWAS carried out primarily in Africa, which implicates a region downstream of the Wilms tumour 1 (WT1) gene that has signatures of positive selection in East Asians 33, 136 .
AIDS.
During the 1980s, the highly variable and fast evolving retroviral pathogen HIV-1 emerged to cause a global infectious disease pandemic that has killed >30 million people 140 . HIV-1 infects immune cells and causes a progressive and incurable failure of the immune system that allows other opportunistic infections, such as tuberculosis, to take hold. Both HIV-1 and the distantly related virus HIV-2 are predicted to be recent (<100 years) cross-species transmissions of simian immunodeficiency viruses (SIVs) into humans 141 . SIVs are mostly non-pathogenic species-specific lentiviruses carried by at least 41 African primate species 142 . Some SIVs have infected the same host for >30,000 years and probably much longer 143 . In the last century, at least ten primate-to-human SIV transmissions have been documented 142 . This suggests that human populations, particularly those in Africa, may have experienced ancient lentivirus epidemics and driven variants that confer resistance to modern HIV strains to prevalence through natural selection. The role of host genetics in HIV infection has been extensively researched, and the NIH Catalog of published GWASs lists at least 15 HIVrelated publications (4 of which report significant associations of P < 1 × 10 −8 ), but any connection to ancient selection remains unclear.
Among the first HIV resistance variants to be elucidated is a 32-base deletion in the cell surface receptor gene CCR5 (known as CCR5Δ32) that prevents the expression of the receptor on T cells and confers complete HIV immunity on homozygous carriers 144, 145 . On the bases of the high prevalence of the variant in northern Europe and the apparently high LD with nearby variants, some researchers hypothesized that CCR5Δ32 was <1,000 years old and that positive selection for resistance to Yersinia pestis (the causative agent of the plague) increased its prevalence 146 , which led to various follow-on studies. However, re-evaluation of the locus using newer and denser genetic maps found no evidence to support positive selection acting on this locus, which highlights the necessity of dense genome-wide data sets when identifying loci with exceptional patterns of variation 147 . Subsequent work on CCR5 highlights the medical relevance of identifying naturally occurring resistance variants. Patients infused with autologous CD4 T cells that are engineered with a CCR5-disrupting mutation designed to phenotypically mimic CCR5Δ32 showed partial resistance to HIV infection 148 . The strongest signals of HIV resistance are in the MHC loci, which are under extreme positive and balancing selection. In a GWAS comparing individuals infected with HIV who do not develop clinical disease (that is, HIV controllers) to individuals with advanced disease, MHC variants provided an explanation for 19% of the phenotypic variance 49 . They included a protective regulatory variant that is correlated with increased expression of human leukocyte antigen C (HLA-C) 149 . Although higher HLA-C expression protects against HIV progression, it also increases risk of the inflammatory disorder Crohn's disease 150 , which highlights the potential for health repercussions of pathogen-driven selection.
Cholera. Cholera -a notoriously deadly disease with historic mortality rates as high as 50% [151] [152] [153] -is caused by the V. cholerae bacterium and endemic to the Ganges River Delta 154 of Bangladesh, where cholera is still prevalent now [155] [156] [157] . Host genetic factors strongly influence susceptibility 69, 70 to this dangerous pathogen, which suggests selection favouring cholera resistance variants. Consistent with this hypothesis, the region has the world's lowest prevalence of blood type O, which is associated with an increased risk of severe cholera 69, 70 . A genome-wide scan for positive selection in a Bangladeshi population identified >300 selected regions. The most strongly selected genes were also associated with cholera susceptibility in a targeted analysis 158 . A gene set enrichment analysis 159 found that two types of genes were statistically overrepresented in the selected regions compared with the rest of the genome: genes encoding potassium channels that are involved in cyclic AMP-mediated chloride secretion, and genes encoding components of the innate immune system that are involved in nuclear factor-κB (NF-κB) signalling. The success of the enrichment analysis suggests that cholera resistance in Bangladesh, similarly to pigmentation in Europe, provides an exceptionally strong evolutionary advantage and has driven selection at many different genomic loci.
The history of selection could make GWASs of cholera susceptibility in Bangladesh particularly powerful. As cholera is still common in Bangladesh, unlike leprosy in Europe, such a study is feasible. The results could help to elucidate the power for mapping positively selected resistance variants that protect against other pathogens with geographical disparity and high mortality.
Pleiotropic effects
Effects on multiple unrelated phenotypes.
Norovirus. The single-stranded RNA viruses of the genus Norovirus are the leading cause of extremely contagious viral gastroenteritis outbreaks worldwide 160 ; they are particularly dangerous to young children and cause up to 200,000 deaths each year in developing countries 161 . The origin of Norovirus is obscured by the rapid evolution of these viruses [162] [163] [164] , but complex signals of selection in humans suggest that they could be very old. Individuals who are homozygous for null mutations of the fucosyltransferase 2 (FUT2) gene do not secrete ABO antigens and are protected against some strains [165] [166] [167] . Non-secretors are common worldwide (for example, in 20% of Caucasians). The underlying FUT2 mutational spectrum is unexpectedly complex, as it is comprised of multiple independent mutations that vary in frequency between populations and that have diverse evolutionary signatures, from long-term balancing selection to recent positive selection 168 .
Influenza. Great pandemics inflict massive mortality and are of particular interest to evolutionary geneticists. The most striking modern example is the 1918 influenza pandemic, which was caused by an unusually lethal strain of influenza A that killed 50-100 million people, including many previously healthy young adults 169, 170 . Influenza is almost certainly very old: Hippocrates described a flu-like illness ~2,400 years ago 171 . Observational data suggest that host genetics influences susceptibility to severe illness 172 ; for example, cases of the highly pathogenic H5N1 strain show strong familial aggregation 173 . Recently, interferoninduced transmembrane proteins (IFITMs) have been implicated in resistance to influenza A. IFITMs inhibit in vitro replication of some pathogenic viruses 174 , and IFITM3 expression protects against infection by multiple strains of influenza A in vitro and in vivo 175 . Hospitalized patients with severe influenza were significantly more likely to carry a splice acceptor site variant in IFITM3 that reduces its ability to restrict influenza virus replication in vitro 175 . Versions of IFITM3 that protect against influenza seem likely to confer a selective advantage, and selection scans show signals of recent positive selection in the IFITM3 region 175 .
Smallpox. Only a century ago, smallpox -caused by the Variola virus -ravaged human societies with mortality rates of up to 30%. It was an ancient and widespread scourge, and was described in historical records thousands of years old from China, India and Egypt. It is now gone and represents the only infectious disease in humans that has been eradicated by modern medicine. Variola virus has a highly conserved (>99.6% across 45 isolates) 186-kb double-stranded DNA genome 176 . Its extremely low mutation rate, simple genetic makeup and reliance on humans as its only host limited its ability to adapt and facilitated its eradication.
The age and phylogeography of smallpox is unresolved despite efforts to integrate historical records with sequence data from 45 viral isolates 176, 177 . We noted that, for 32 viral isolates with documented mortality, death rates are lower in Africa (0.4−12%) than elsewhere (4−38%), even though all isolates were from a single phylogenetic clade 178 . This is consistent with selection for resistance in Africa, where the smallpox virus is predicted to have evolved from a rodent-borne ancestor tens of thousands of years ago and where outbreaks of other poxviruses continue nowadays. Human evolutionary history may help to clarify the origins of smallpox.
With smallpox eradicated, vaccine response is used as a crude phenotypic proxy for studying host resistance. Two GWASs that included European, African American and Hispanic populations identified 37 SNPs associated with cytokine response to vaccination 179, 180 (P < 1 × 10 −8
). Most of the significant associations (65%) were found in African Americans, even though their sample size was half of that of the European cohorts, which is consistent with a larger effect due to selection in Africa. These results are preliminary: the studies had relatively small sample sizes (~200 African Americans), no overlap in their results and no replication. Incorporating tests for natural selection could add power for detecting true associations.
Infectious disease selection and common disease
The hygiene hypothesis proposes that autoimmune disorders are partly caused by differences between the pathogen-rich environment in which our immune system evolved and the more sterile modern world. In the absence of diverse pathogens from which to defend ourselves, our immune responses may turn on us 12 . Loci associated with common inflammatory disorders are enriched for signals of positive selection 1, [181] [182] [183] , and GWASs have proved particularly powerful for this class of diseases 184 . Elucidating the effect of ancient selection for pathogen resistance should help to decipher the aetiology of autoimmune diseases 89 but will require more data on immune responses to common pathogens. In cases in which selected variants have pleiotropic effects, pathogen-driven selection may even underlie diseases with no apparent immune component.
Inflammatory bowel disease.
Inflammatory bowel disease (IBD) is a group of disorders, including Crohn's disease and ulcerative colitis, that are caused by autoimmune attacks on the gastrointestinal system. One hundred and sixty-three distinct loci have been significantly associated with IBD risk using meta-analyses of up to 75,000 European cases and controls, and these loci are strongly enriched for signatures of selection 11, 117 . Moreover, seven of the eight leprosy susceptibility loci 52, 126 are also associated with increased IBD risk 54, 125 . Risk allele frequencies at some IBD loci correlate with local pathogen diversity, which is consistent with pathogen-driven selection 185 . These observations broadly support the hygiene hypothesis and connect autoimmunity to ancient evolution for pathogen resistance. However, the relationship is not straightforward. Of the four leprosy risk loci that precisely overlap IBD association peaks 11 , the IBD risk variant is associated with decreased leprosy risk at only two loci; the other two associate with increased risk. Further complicating the story, one of those two -the variant in NOD2 -is associated with both an increased risk of Crohn's disease and protection against ulcerative colitis 186 . One potential source of the seemingly discrepant GWAS results is population differences. Whereas the 163 IBD loci were identified in cohorts of European ancestry, the leprosy GWASs were carried out in East Asian populations. The NOD2 pathway association with leprosy resistance in East Asians has not been replicated in other populations 127 . In addition, East Asians rarely carry the functional knockout mutation in TLR1 that is common in Europe. Experimental data suggest that TLR1 and NOD2 activate distinct pathways in response to leprosy infection 187 ; thus, correlating East Asian pathogen resistance variants with autoimmune disease risk in Europeans may not be informative.
A second factor is simply the lack of data on many pathogens. The remarkable overlap between GWAS loci of leprosy and IBD may reflect a bias in the available data, as leprosy is only one of the few pathogen susceptibility GWASs completed. Not a single GWAS has been carried out, for example, on susceptibility to parasitic worms, which are potentially of great relevance to gastrointestinal disorders such as IBD.
Coeliac disease. Coeliac disease is a strongly heritable 188 (~80%) inflammatory intestinal disorder triggered by gluten consumption. Despite severely affecting nutritional intake, coeliac disease occurs at 1-2% in Europe 189 and up to 6% in North African Sahrawi 190 . Loci associated with coeliac disease have signatures of positive selection 181 . A functional analysis of one selected locus in the SH2B adaptor protein 3 (SH2B3) gene found that individuals who are homozygous for the coeliac risk allele (~22% of the European population) have stronger activation of the NOD2 pathway and a 3-5-fold higher pro-inflammatory cytokine response to lipopolysaccharide 191 . Better protection against bacterial infection may have conferred a selective advantage that outweighed the increased risk of coeliac disease risk. Inferring selection pressure is problematic, as gluten consumption and thus the selection against coeliac disease probably changed with agriculture. A crude estimate of the age of the SH2B3 variant based simply on haplotype length suggested that it was very recent 191 (<2,000 years old). However, simulations suggest that the long haplotype tests used to detect the selection at SH2B3 are sensitive to selection events ~5,000-50,000 years ago 28 , which implies that the SH2B3 selection could date to either before or after the spread of agriculture through Europe ~10,000 years ago 192 . Accurately dating selected variants is challenging and requires methods that can both estimate multiple parameters and test various ancestry models, such as Approximate Bayesian Computation 193 .
Non-autoimmune disease: kidney disease. African Americans suffer from kidney disease -including focal segmental glomerulosclerosis (FSGS) and hypertensionattributed end-stage kidney disease (H-ESKD) -at higher rates than European Americans. A region around the myosin heavy chain gene MYH9 was associated with FSGS and H-ESKD in African Americans, but no causal variants were found 194, 195 . One study 86 expanded the search to include an adjacent signal of African positive selection at the APOL1 gene. Using data from the 1000 Genomes Project, they tested all polymorphisms with large frequency differences between Africans and Europeans in this expanded interval and identified two independent coding variants in APOL1 that are strongly associated with FSGS (odds ratio = 10.5) and H-ESKD (odds ratio = 7.3). In vitro assays showed that the kidney disease-associated variants lyse T. brucei rhodesiense, which is the trypanosome parasite that causes the most acute, virulent form of sleeping sickness (FIG. 3B) . The authors propose that ancient selection for resistance to sleeping sickness or a related pathogen in Africa contributes to the high rates of kidney disease in African Americans.
Conclusion
One of the oldest topics in genetics -natural selection for pathogen resistance -is being transformed by highthroughput biotechnology that offers unprecedented power to examine genome evolution. New research finds that both the most ancient signals of balancing selection (on cell surface glycoproteins) and some of the clearest signals of recent positive selection (on TLRs) implicate pathogens as the strongest selective pressure to drive the evolution of modern humans. Incorporating ancient history into disease susceptibility studies will identify functional variants and elucidate cellular mechanisms, and facilitate the development of new therapies for a surprisingly wide range of human illnesses. The range of diseases affected by ancient pathogen-driven selection extends beyond infectious diseases and immunemediated disorders. Inflammatory and immunity genes are associated with psychiatric diseases, including schizophrenia 196 and autism 197 , and the role of host genetics in maintaining a healthy microbiome is only starting to be examined 14 . At the dawn of genomic medicine, our ancient evolutionary history is one of our most powerful resources for understanding human biology towards improving human health.
